Abstract

BackgroundSubstituted flavanoids interfere with uncoating of Enteroviruses including Sabin-2 polio vaccine strains. However flavanoid resistant and dependent, type-2 polio vaccine strains (minimally-diverged), emerged during in vitro infections. Between 1998–2009, highly-diverged (8 to >15%) type-2, aVDPV2s, from two unrelated persistent infections were periodically isolated from Israeli sewage.AimTo determine whether highly evolved aVDPV2s derived from persistent infections retained sensitivity to isoflavenes.MethodsSabin-2 and ten aVDPV2 isolates from two independent Israeli sources were titered on HEp2C cells in the presence and absence of 3(2H)- Isoflavene and 6-chloro-3(2H)-Isoflavene. Neurovirulence of nine aVDPV2s was measured in PVR-Tg-21 transgenic mice. Differences were related to unique amino acid substitutions within capsid proteins.Principal FindingsThe presence of either flavanoid inhibited viral titers of Sabin-2 and nine of ten aVDPV2s by one to two log10. The tenth aVDPV2, which had unique amino acid substitution distant from the isoflavene-binding pocket but clustered at the three- and five-fold axies of symmetry between capsomeres, was unaffected by both flavanoids. Genotypic neurovirulence attenuation sites in the 5′UTR and VP1 reverted in all aVDPV2s and all reacquired a full neurovirulent phenotype except one with amino acid substitutions flanking the VP1 site.ConclusionBoth isoflavenes worked equally well against Sabin 2 and most of the highly-diverged, Israeli, aVDPV2s isolates. Thus, functionality of the hydrophobic pocket may be unaffected by selective pressures exerted during persistent poliovirus infections. Amino acid substitutions at sites remote from the drug-binding pocket and adjacent to a neurovirulence attenuation site may influence flavanoid antiviral activity, and neurovirulence, respectively.

Highlights

  • Poliovirus is a member of the Picornaviridae

  • Functionality of the hydrophobic pocket may be unaffected by selective pressures exerted during persistent poliovirus infections

  • Mutations that interfered with the antiviral activity of these compounds appeared during in vitro replication of type 2 polio vaccine strains in the presence of these compound [4]

Read more

Summary

Introduction

Poliovirus is a member of the Picornaviridae. Like other members of the Picornaviridae, poliovirus RNA is encapsidated in an icosahedral structure with axes of three-fold and five-fold symmetry formed from 60 capsomeres containing one copy each of viral capsid proteins VP1, VP2, VP3 and VP4 [1]. Flavanoids and flavonoids were shown to have antiviral activity in vitro against several picornaviruses including type 2 polioviruses [3,4,5,6,7,8]. These compounds act primarily by occupying the hydrophobic pocket, interfering with virus uncoating. They did not directly affect viral adsorption or RNA synthesis [4]. Between 1998–2009, highly-diverged (8 to .15%) type-2, aVDPV2s, from two unrelated persistent infections were periodically isolated from Israeli sewage

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call